Pembroke Management LTD lowered its stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN – Free Report) by 1.4% during the fourth quarter, Holdings Channel.com reports. The fund owned 305,219 shares of the company’s stock after selling 4,295 shares during the period. Ryan Specialty accounts for approximately 2.5% of Pembroke Management LTD’s holdings, making the stock its 16th largest holding. Pembroke Management LTD’s holdings in Ryan Specialty were worth $19,583,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Signaturefd LLC raised its holdings in shares of Ryan Specialty by 12.3% during the 3rd quarter. Signaturefd LLC now owns 1,347 shares of the company’s stock worth $89,000 after buying an additional 148 shares in the last quarter. Wealth Enhancement Advisory Services LLC purchased a new stake in shares of Ryan Specialty during the 3rd quarter valued at $753,000. State of Alaska Department of Revenue grew its stake in shares of Ryan Specialty by 7.2% during the 3rd quarter. State of Alaska Department of Revenue now owns 11,940 shares of the company’s stock worth $792,000 after acquiring an additional 805 shares during the period. Boston Financial Mangement LLC raised its stake in shares of Ryan Specialty by 0.5% during the 3rd quarter. Boston Financial Mangement LLC now owns 452,489 shares of the company’s stock valued at $30,041,000 after purchasing an additional 2,269 shares during the period. Finally, Stephens Inc. AR purchased a new stake in shares of Ryan Specialty in the third quarter worth $289,000. 84.82% of the stock is owned by institutional investors.
Analyst Ratings Changes
A number of research firms have recently weighed in on RYAN. Morgan Stanley started coverage on Ryan Specialty in a research note on Thursday, December 5th. They issued an “overweight” rating and a $90.00 target price for the company. Wells Fargo & Company dropped their price target on Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating on the stock in a research note on Tuesday, January 14th. Barclays raised their price objective on shares of Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research report on Thursday, November 21st. Finally, Keefe, Bruyette & Woods cut their target price on shares of Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating for the company in a report on Friday, January 10th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat, Ryan Specialty presently has a consensus rating of “Hold” and an average target price of $74.40.
Insider Buying and Selling at Ryan Specialty
In related news, Director David P. Bolger sold 7,055 shares of the business’s stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $70.88, for a total value of $500,058.40. Following the completion of the sale, the director now directly owns 78,149 shares of the company’s stock, valued at $5,539,201.12. The trade was a 8.28 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Nicholas Dominic Cortezi sold 31,409 shares of Ryan Specialty stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $65.64, for a total transaction of $2,061,686.76. Following the completion of the sale, the director now owns 2,697 shares in the company, valued at approximately $177,031.08. This represents a 92.09 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 323,506 shares of company stock worth $21,407,851. Corporate insiders own 11.10% of the company’s stock.
Ryan Specialty Trading Up 0.2 %
Shares of Ryan Specialty stock opened at $68.75 on Tuesday. The company’s 50-day simple moving average is $65.53 and its 200-day simple moving average is $67.23. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The firm has a market cap of $18.00 billion, a price-to-earnings ratio of 89.29, a price-to-earnings-growth ratio of 1.19 and a beta of 0.72. Ryan Specialty Holdings, Inc. has a 52-week low of $44.84 and a 52-week high of $75.97.
Ryan Specialty Profile
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Featured Stories
- Five stocks we like better than Ryan Specialty
- Technology Stocks Explained: Here’s What to Know About Tech
- Airbnb’s Earnings: Sky High Results, Grounded Guidance?
- 5 Top Rated Dividend Stocks to Consider
- Kyndryl Soars on AI, Cybersecurity Growth—What’s Next?
- How to Start Investing in Real Estate
- Conflicting Signals: Tempus AI’s Stock Market Rally
Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings, Inc. (NYSE:RYAN – Free Report).
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.